Immune to Cancer: The CRI Blog
-
Clinical Trials Drive Immunotherapy Progress. Are They for You?
Immunotherapy clinical trials are critical endeavors that lead to breakthrough cancer treatments.
-
Dr. Kunle Odunsi Answers Questions About Immunotherapy Clinical Trials After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi, of the University of Chicago Medicine Comprehensive Cancer Center, answers questions about immunotherapy clinical…
-
COVID-19’s Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis
A new CRI report highlights the impact of the COVID-19 pandemic on cancer clinical trials compared to…
-
CRI-Funded Trial Highlights New Hope Against Pancreatic Cancer
New publication from the CRI PRINCE trial highlights benefits of an immunotherapy-chemotherapy combination against advanced pancreatic cancer.
-
Dr. Ezra Cohen Answers Questions About Immunotherapy Clinical Trials from the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Ezra Cohen, of UC San Diego Moores Cancer Center, answers questions about immunotherapy clinical trials from…
-
Immunotherapy Clinical Trials with Dr. Ezra Cohen at the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Ezra Cohen addresses myths, questions, and other concerns about cancer immunotherapy clinical trials at the 2020…
-
Advances in Immunotherapy for Prostate Cancer with Dr. Sumit Subudhi
For Prostate Cancer Awareness Month, CRI spoke with Dr. Sumit Subudhi about advances in immunotherapy for prostate…
-
How Immunotherapy Is Transforming Bladder Cancer Treatment
Arjun V. Balar, MD, discusses checkpoint immunotherapy, new FDA approvals, promising new therapies, and clinical trials for…
-
How COVID-19 is Impacting Care for Blood Cancer Patients
CRI spoke with Dr. Melody Smith about how clinical care for leukemia, lymphoma, and multiple myeloma patients…